
Atossa Therapeutics, Inc.
Atossa Therapeutics, Inc.(ATOS)股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
atos · 股价预测 · 5 位分析师(近3月)· FMP · 更新于 2026年6月9日
分析师评级与共识
基于过去 3 个月内 5 位华尔街分析师
Buy
5 位分析师
共识
评级分布
12 个月目标价
High
$10.00
Consensus
$10.00
+119.8% upside
Low
$10.00
Median: $10 · Last Close: $4.55
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
短期股价预测
Low Activity算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $4.40 | ↓ 3.22% |
1-day model range: $4.33–$4.48. Peak: $4.48 (-3.22%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | — | -50.0% |
| 2028 | — | -62.5% |
| 2029 | — | -67.2% |
| 2030 | — | -69.2% |
| 2031 | — | -70.2% |
基于技术分析的股价预测
14 项技术面信号(SMA×6 + EMA×6 + RSI + MACD)· EEAT 方法论透明
Insufficient Trading Activity — Sentiment Signals Disabled
This stock has very low trading volume (ZOMBIE condition). Sentiment analysis requires sufficient price action. RSI and MACD values below are still shown for reference.
Moving Averages · ATOS · Jun 9, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-04-10 | Ascendiant Capital | Maintains | Buy→Buy |
| 2026-03-26 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-12-08 | Ascendiant Capital | Maintains | Buy→Buy |
| 2025-09-22 | Ascendiant Capital | Maintains | Buy→Buy |
| 2025-06-06 | Ascendiant Capital | Maintains | Buy→Buy |
| 2025-04-21 | Ascendiant Capital | Maintains | Buy→Buy |
| 2025-03-26 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-03-12 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-01-30 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-12-13 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Atossa Therapeutics, Inc. (ATOS) stock. Of the recent 28 rating actions, 1 were upgrades and 1 were downgrades. 5 analysts currently cover ATOS.
分析师推荐趋势
ATOS analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
财务预测:EPS 与营收一致预期
Revenue This Year
$54M
↓ 33.1% YoY
Revenue Next Year
$82M
↑ 51.2% YoY
EPS This Year
$-4.41
EPS Next Year
$-2.72
↓ 38.3% YoY
EPS ForecastReported vs Estimated
Analysts forecast ATOS EPS of $-4.41 for the current fiscal year, based on estimates from 2 analysts. The ATOS revenue forecast is $54M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
ATOS 股价预测由两类独立数据源支撑:来自 5 位华尔街分析师(S&P Global / FMP)的共识评级,以及基于历史日终价计算的技术分析。ATOS 的共识目标价为 $10.00(+119.8% 上行空间),分析师共识为 Buy。
ATOS 的短期预测(明日)为 $4.40(-3.22%)。 ATOS 对 2030 年的预测区间为 $1–$2。
Atossa Therapeutics, Inc. 在 NASDAQ 上市,代码 ATOS。ATOS 在 2027 年的整体展望偏积极,在覆盖分析师中约 80% 对应 Buy 共识。
常见问题
ATOS 预测 · 8 个问题根据 5 位华尔街分析师,ATOS 的 12 个月平均目标价为 $10.00,最高 $10.00、最低 $10.00。若有图表,中位目标价可在上方查看。相对当前价 $4.55,隐含约 +119.8% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.